Skip to main content
. 2016 Jan 1;6(1):104–117. doi: 10.7150/thno.13580

Figure 7.

Figure 7

Therapeutic efficacy of 177Lu-JMV4168 to treat subcutaneous PC-3 tumors. Tumor size (A) and weight (B) follow up of mice treated with four injections of 177Lu-JMV4168 (50 MBq, 200 pmol) on days 0, 2, 4 and 6, with or without PA (n=12 per group).